• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨髓间充质干细胞衍生的外泌体通过抑制细胞凋亡和炎症缓解大鼠糖尿病肾病。

Bone Marrow Mesenchymal Stem Cell-Derived Exosomes Alleviate Diabetic Kidney Disease in Rats by Inhibiting Apoptosis and Inflammation.

机构信息

Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, 100029 Beijing, China.

Department of Cardiology, The Second Affiliated Hospital of Shandong First Medical University, 271000 Taian, Shandong, China.

出版信息

Front Biosci (Landmark Ed). 2023 Sep 14;28(9):203. doi: 10.31083/j.fbl2809203.

DOI:10.31083/j.fbl2809203
PMID:37796685
Abstract

BACKGROUND AND AIMS

Previous studies have confirmed the anti-inflammation effect of bone marrow mesenchymal stem cell-derived exosomes (BMSC-Exo). We aimed to investigate the therapeutic effect of BMSC-Exo on diabetic kidney disease (DKD), as well as the underlying mechanisms.

METHODS

SD rats were induced by streptozotocin combined with a high-fat diet to establish a diabetes disease model. BMSCs-Exo were injected via tail veins at a weekly dose of 100 µg for 12 weeks. Pathological changes in the rat kidneys were evaluated using HE, Masson, and Periodic Acid-Schiff and immunohistochemical staining. TUNEL staining and western blot were used to evaluate the expression levels of apoptosis-related proteins in the rat kidney cells. The TNF-α level was detected by PCR and NF-κB (p65) by western blotting to examine the inflammatory responses in the renal tissue.

RESULTS

BMSCs-Exo significantly alleviated the renal structural damage and the distribution of apoptotic cells in diabetic rats. Furthermore, BMSCs-Exo increased the expression of pro-apoptosis protein Bax and decreased the expression of apoptosis-executing protein Cleaved Caspase 9 and Cleaved caspase 3. In addition, the transcription level of TNF-α in kidney tissue and NF-κB (p65) expression was also decreased through BMSCs-Exo treatment. Besides, the levels of glucose (GLU), creatinine (Cr), and burea nitrogen (BUN) in diabetic rats were decreased by the BMSC-Exo treatment.

CONCLUSIONS

BMSCs-Exo may alleviate diabetic kidney damage by inhibiting apoptosis and inflammation.

摘要

背景与目的

先前的研究已经证实骨髓间充质干细胞来源的外泌体(BMSC-Exo)具有抗炎作用。我们旨在研究 BMSC-Exo 对糖尿病肾病(DKD)的治疗作用及其潜在机制。

方法

SD 大鼠通过链脲佐菌素联合高脂饮食诱导建立糖尿病疾病模型。每周通过尾静脉注射 BMSC-Exo 100μg,持续 12 周。使用 HE、Masson、过碘酸希夫和免疫组织化学染色评估大鼠肾脏的病理变化。TUNEL 染色和 Western blot 用于评估大鼠肾脏细胞中凋亡相关蛋白的表达水平。通过 PCR 检测 TNF-α 水平,通过 Western blot 检测 NF-κB(p65),以检查肾脏组织中的炎症反应。

结果

BMSC-Exo 显著减轻了糖尿病大鼠的肾脏结构损伤和凋亡细胞的分布。此外,BMSC-Exo 增加了促凋亡蛋白 Bax 的表达,降低了凋亡执行蛋白 Cleaved Caspase 9 和 Cleaved caspase 3 的表达。此外,通过 BMSC-Exo 处理还降低了肾脏组织中 TNF-α 的转录水平和 NF-κB(p65)的表达。此外,BMSC-Exo 治疗还降低了糖尿病大鼠的血糖(GLU)、肌酐(Cr)和尿素氮(BUN)水平。

结论

BMSC-Exo 可能通过抑制细胞凋亡和炎症来减轻糖尿病肾病的损伤。

相似文献

1
Bone Marrow Mesenchymal Stem Cell-Derived Exosomes Alleviate Diabetic Kidney Disease in Rats by Inhibiting Apoptosis and Inflammation.骨髓间充质干细胞衍生的外泌体通过抑制细胞凋亡和炎症缓解大鼠糖尿病肾病。
Front Biosci (Landmark Ed). 2023 Sep 14;28(9):203. doi: 10.31083/j.fbl2809203.
2
[Exosomes derived from bone marrow mesenchymal stem cells regulate NF-κB pathway and reduce lung ischemia-reperfusion injury in rats by miR-335].骨髓间充质干细胞来源的外泌体通过miR-335调节NF-κB通路并减轻大鼠肺缺血再灌注损伤
Sheng Li Xue Bao. 2024 Apr 25;76(2):247-256.
3
Mesenchymal stem cell-derived exosomes ameliorate diabetic kidney disease through NOD2 signaling pathway.间充质干细胞来源的外泌体通过 NOD2 信号通路改善糖尿病肾病。
Ren Fail. 2024 Dec;46(2):2381597. doi: 10.1080/0886022X.2024.2381597. Epub 2024 Jul 22.
4
Bone Mesenchymal Stem Cells Origin Exosomes are Effective Against Sepsis-Induced Acute Kidney Injury in Rat Model.骨髓间充质干细胞来源的外泌体对大鼠脓毒症诱导的急性肾损伤有效。
Int J Nanomedicine. 2023 Dec 18;18:7745-7758. doi: 10.2147/IJN.S417627. eCollection 2023.
5
Bone marrow mesenchymal stem cell-secreted exosomes carrying microRNA-125b protect against myocardial ischemia reperfusion injury via targeting SIRT7.骨髓间充质干细胞分泌的携带 microRNA-125b 的外泌体通过靶向 SIRT7 保护心肌缺血再灌注损伤。
Mol Cell Biochem. 2020 Feb;465(1-2):103-114. doi: 10.1007/s11010-019-03671-z. Epub 2019 Dec 19.
6
Bone marrow mesenchymal stem cells-derived exosomes reduce apoptosis and inflammatory response during spinal cord injury by inhibiting the TLR4/MyD88/NF-κB signaling pathway.骨髓间充质干细胞来源的外泌体通过抑制 TLR4/MyD88/NF-κB 信号通路减少脊髓损伤中的细胞凋亡和炎症反应。
Hum Exp Toxicol. 2021 Oct;40(10):1612-1623. doi: 10.1177/09603271211003311. Epub 2021 Mar 29.
7
Exosomes with high level of miR-181c from bone marrow-derived mesenchymal stem cells inhibit inflammation and apoptosis to alleviate spinal cord injury.骨髓间充质干细胞来源的高表达 miR-181c 的外泌体抑制炎症和细胞凋亡,从而减轻脊髓损伤。
J Mol Histol. 2021 Apr;52(2):301-311. doi: 10.1007/s10735-020-09950-0. Epub 2021 Feb 6.
8
Bone marrow mesenchymal stem cells ameliorated kidney fibrosis by attenuating TLR4/NF-κB in diabetic rats.骨髓间充质干细胞通过减轻糖尿病大鼠 TLR4/NF-κB 减轻肾纤维化。
Life Sci. 2020 Dec 1;262:118385. doi: 10.1016/j.lfs.2020.118385. Epub 2020 Sep 11.
9
PTH (1-34) enhances the therapeutic effect of bone marrow mesenchymal stem cell-derived exosomes by inhibiting proinflammatory cytokines expression on OA chondrocyte repair in vitro.PTH(1-34)通过抑制体外 OA 软骨细胞修复中的促炎细胞因子表达,增强骨髓间充质干细胞来源的外泌体的治疗效果。
Arthritis Res Ther. 2022 Apr 29;24(1):96. doi: 10.1186/s13075-022-02778-x.
10
[Inhibitory effect and mechanism of bone marrow mesenchymal stem cells on inflammation in rats with multiple organ dysfunction syndrome].骨髓间充质干细胞对多器官功能障碍综合征大鼠炎症的抑制作用及机制
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2022 Aug;38(8):673-678.

引用本文的文献

1
Stem Cell-Derived Exosomes: A Comprehensive Review of Biomedical Applications, Challenges, and Future Directions.干细胞衍生外泌体:生物医学应用、挑战及未来方向的全面综述
Int J Nanomedicine. 2025 Sep 4;20:10857-10905. doi: 10.2147/IJN.S527137. eCollection 2025.
2
Exo-hydrogel therapy: a revolutionary approach to managing diabetic complications.外泌体水凝胶疗法:一种治疗糖尿病并发症的革命性方法。
J Nanobiotechnology. 2025 Aug 11;23(1):558. doi: 10.1186/s12951-025-03621-6.
3
Emerging roles of exosomes in the diagnosis and treatment of kidney diseases.
外泌体在肾脏疾病诊断和治疗中的新作用。
Front Pharmacol. 2025 Apr 16;16:1525314. doi: 10.3389/fphar.2025.1525314. eCollection 2025.
4
Mesenchymal Stem Cell Therapy: Therapeutic Opportunities and Challenges for Diabetic Kidney Disease.间充质干细胞治疗:糖尿病肾病的治疗机会和挑战。
Int J Mol Sci. 2024 Sep 30;25(19):10540. doi: 10.3390/ijms251910540.
5
Thiazolidine-2,4-dione hybrids as dual alpha-amylase and alpha-glucosidase inhibitors: design, synthesis, and anti-diabetic evaluation.噻唑烷-2,4-二酮杂合物作为双α-淀粉酶和α-葡萄糖苷酶抑制剂:设计、合成及抗糖尿病评价
RSC Med Chem. 2024 Jul 22;15(8):2826-2854. doi: 10.1039/d4md00199k. eCollection 2024 Aug 14.
6
Impact of very low carbohydrate ketogenic diets on cardiovascular risk factors among patients with type 2 diabetes; GRADE-assessed systematic review and meta-analysis of clinical trials.极低碳水化合物生酮饮食对2型糖尿病患者心血管危险因素的影响;GRADE评估的临床试验系统评价和荟萃分析
Nutr Metab (Lond). 2024 Jul 19;21(1):50. doi: 10.1186/s12986-024-00824-w.